149 related articles for article (PubMed ID: 37517447)
21. Early pregnancy termination with mifepristone and misoprostol in the United States.
Spitz IM; Bardin CW; Benton L; Robbins A
N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
[TBL] [Abstract][Full Text] [Related]
22. Flexible mifepristone and misoprostol administration interval for first-trimester medical termination.
Wedisinghe L; Elsandabesee D
Contraception; 2010 Apr; 81(4):269-74. PubMed ID: 20227541
[TBL] [Abstract][Full Text] [Related]
23. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
24. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
el-Refaey H; Hinshaw K; Templeton A
Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
26. Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials.
Hou SP; Fang AH; Chen QF; Huang YM; Chen OJ; Cheng LN
Contraception; 2011 Sep; 84(3):214-23. PubMed ID: 21843683
[TBL] [Abstract][Full Text] [Related]
27. A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.
Dzuba IG; Castillo PW; Bousiéguez M; Lugo Hernández EM; Castañeda Vivar JJ; Sanhueza Smith P
Contraception; 2020 Aug; 102(2):104-108. PubMed ID: 32474060
[TBL] [Abstract][Full Text] [Related]
28. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
29. Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation.
Hsia JK; Lohr PA; Taylor J; Creinin MD
Contraception; 2019 Sep; 100(3):178-181. PubMed ID: 31102629
[TBL] [Abstract][Full Text] [Related]
30. Combination of Mifepristone and Misoprostol for First-Trimester Medical Abortion: A Comprehensive Review of the Literature.
Kelesidou V; Tsakiridis I; Virgiliou A; Dagklis T; Mamopoulos A; Athanasiadis A; Kalogiannidis I
Obstet Gynecol Surv; 2024 Jan; 79(1):54-63. PubMed ID: 38306292
[TBL] [Abstract][Full Text] [Related]
31. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting.
Goldstone P; Walker C; Hawtin K
Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):366-371. PubMed ID: 28303569
[TBL] [Abstract][Full Text] [Related]
33. Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.
Elami-Suzin M; Freeman MD; Porat N; Rojansky N; Laufer N; Ben-Meir A
Obstet Gynecol; 2013 Oct; 122(4):815-820. PubMed ID: 24084539
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of medical abortion prior to 6 gestational weeks: a systematic review.
Kapp N; Baldwin MK; Rodriguez MI
Contraception; 2018 Feb; 97(2):90-99. PubMed ID: 28935220
[TBL] [Abstract][Full Text] [Related]
35. Early abortion. Update and implications for midwifery practice.
Narrigan D
J Nurse Midwifery; 1998; 43(6):492-501. PubMed ID: 9871382
[TBL] [Abstract][Full Text] [Related]
36. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
Bartley J; Baird DT
BJOG; 2002 Nov; 109(11):1290-4. PubMed ID: 12452468
[TBL] [Abstract][Full Text] [Related]
37. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
Ashok PW; Flett GM; Templeton A
Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of medical abortion: a meta-analysis.
Kahn JG; Becker BJ; MacIsaa L; Amory JK; Neuhaus J; Olkin I; Creinin MD
Contraception; 2000 Jan; 61(1):29-40. PubMed ID: 10745067
[TBL] [Abstract][Full Text] [Related]
40. Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial.
Dickinson JE; Jennings BG; Doherty DA
Obstet Gynecol; 2014 Jun; 123(6):1162-1168. PubMed ID: 24807339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
